Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to palovarotene, which is being developed for the treatment of fibrodysplasia ossificans progressiva (FOP).

1 Dec 2014

Persistent eosinophilia common in COPD

More than one-third of patients with chronic obstructive pulmonary disease have persistent eosinophilia, researchers report in the European Respiratory Journal.

27 Nov 2014

Better evidence needed for relationship between exercise and COPD

Researchers call for high-quality studies investigating the relationship between physical activity and chronic obstructive pulmonary disease after their systematic review found the level of evidence to be poor.

27 Nov 2014

Study shows effectiveness of VolitionRx’s NuQ test in detecting lung cancer in blood and sputum

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that data from its pilot lung cancer study will be presented at the Science for Business BioWin Day 2014, being held November 26, 2014 in Louvain-la-Neuve, Belgium.

25 Nov 2014

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Clementia Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation for palovarotene, the company's lead product candidate, for the treatment of fibrodysplasia ossificans progressiva (FOP).

21 Nov 2014

Apellis Pharmaceuticals signs agreement to acquire Potentia Pharmaceuticals

Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.

20 Nov 2014

Nutrition treatment for older COPD patients shows better outcomes

People aged 65 and older, who were being treated for chronic obstructive pulmonary disease (COPD) in the hospital and received nutrition treatment (oral nutrition supplements) had reduced lengths of stay, hospital costs and chances of returning to the hospital within 30-days, according to a study published in CHEST.

18 Nov 2014

University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

It's well known that battlefield explosions can cause hearing loss, but veterans may be surprised to learn that their vision may also suffer — sometimes weeks or months after combat exposure.

14 Nov 2014

Community pharmacies can help identify COPD at early stage, save £264 million

Using community pharmacies to identify undiagnosed cases of chronic obstructive pulmonary disease (COPD) at an early stage could save £264 million a year according to new research from the University of East Anglia.

12 Nov 2014

Studies evaluate traditional management of heart attack patients after discharge from hospital

Beta-blockers have been a cornerstone in the treatment of heart attack survivors for more than a quarter of a century. However, many of the data predate contemporary medical therapy such as reperfusion, statins, and antiplatelet agents, and recent data have called the role of beta-blockers into question.

12 Nov 2014

New program aims to educate COPD patients on how to manage their disease

The American Thoracic Society today announced a new program, produced with support from Sunovion Pharmaceuticals Inc., to provide materials to educate patients with chronic obstructive pulmonary disease (COPD) about this progressive lung disease and how it can be managed.

11 Nov 2014

LSTM receives research grants to develop Experimental Human Pneumococcal Carriage model

Respiratory specialists at Liverpool School Tropical Medicine (LSTM) have been awarded two substantial research grants to further develop and utilise their Experimental Human Pneumococcal Carriage (EHPC) model.

10 Nov 2014

LSTM awarded research grants to develop Experimental Human Pneumococcal Carriage model

Respiratory specialists at Liverpool School Tropical Medicine have been awarded two substantial research grants to further develop and utilise their Experimental Human Pneumococcal Carriage (EHPC) model.

7 Nov 2014

New algorithm could help determine how to treat patients having difficulty breathing

Paramedics respond to a 911 call to find an elderly patient who's having difficulty breathing. Anxious and disoriented, the patient has trouble remembering all the medications he's taking, and with his shortness of breath, speaking is difficult. Is he suffering from acute emphysema or heart failure? The symptoms look the same, but initiating the wrong treatment regimen will increase the patient's risk of severe complications.

7 Nov 2014

Researchers make significant advancement in early diagnosis of invasive cancers

A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. In a study which has just been published in the journal PLOS ONE, the team shows that it is possible to detect, in patients at risk of developing lung cancer, early signs, in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning.

4 Nov 2014

New policy targeting hospital readmissions for COPD may hurt vulnerable patients, say experts

Last week, the federal government revealed that it will fine more than 2,600 hospitals in the coming year, because too many Medicare patients treated at these hospitals are ending up back in the hospital within 30 days of going home. Two new conditions have been added in this round of penalties: elective hip and knee replacement and chronic lung disease.

3 Nov 2014

LAMA/LABA combination better than monotherapy for severe COPD

Combination treatment with umeclidinium bromide and vilanterol offers clinically meaningful improvements over tiotropium monotherapy for patients with moderate-to-very severe chronic obstructive pulmonary disease, study data show.

31 Oct 2014

Combination therapy beneficial for COPD patients

Research published in JAMA supports the use of a combination of long-acting β-agonists and inhaled corticosteroids in patients with chronic obstructive pulmonary disease.

31 Oct 2014

Severe childhood asthma linked to COPD in adult life

Children with severe asthma are at an increased risk of developing chronic obstructive pulmonary disease in adult life, show findings of an Australian study.

31 Oct 2014

Data reveals sustained local control for early stage lung cancer patients who receive SBRT

Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from 2003 to 2012, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

31 Oct 2014

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Persistent eosinophilia common in COPD

Better evidence needed for relationship between exercise and COPD

Study shows effectiveness of VolitionRx’s NuQ test in detecting lung cancer in blood and sputum

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Apellis Pharmaceuticals signs agreement to acquire Potentia Pharmaceuticals

Nutrition treatment for older COPD patients shows better outcomes

University at Buffalo researchers receive $500,000 grant to study IED-induced vision loss

Community pharmacies can help identify COPD at early stage, save £264 million

Studies evaluate traditional management of heart attack patients after discharge from hospital

New program aims to educate COPD patients on how to manage their disease

LSTM receives research grants to develop Experimental Human Pneumococcal Carriage model

LSTM awarded research grants to develop Experimental Human Pneumococcal Carriage model

New algorithm could help determine how to treat patients having difficulty breathing

Researchers make significant advancement in early diagnosis of invasive cancers

New policy targeting hospital readmissions for COPD may hurt vulnerable patients, say experts

LAMA/LABA combination better than monotherapy for severe COPD

Combination therapy beneficial for COPD patients

Severe childhood asthma linked to COPD in adult life

Data reveals sustained local control for early stage lung cancer patients who receive SBRT

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in